Skip to content

Azenta AZTA Asia Pacific (Excluding China) — Total Revenue

Other geography segments

Rest of Europe
$25.87M+2.4%
Other
$1.09M+6.3%

Similar metrics at other companies

10x Genomics, Inc. logo
TXGAsia-Pacific (excluding China) — Revenue
$18.06M+16.2%
Progress Software logo
PRGSAsia Pacific — Total Revenue
$11.2M-1.5%
Arteris, Inc. logo
AIPAsia Pacific — Total Revenue
$8.4M+20.8%
nLIGHT, Inc. logo
LASRAsia Pacific — Total Revenue
$11.87M+30.1%
GitLab logo
GTLBAsia Pacific — Total Revenue
$6.59M+45.0%
IAR
IARTAsia Pacific — Total Revenues
$45.21M+0.2%

Other financials

Income statement

See full
Revenue$144.8M+1.0%
Gross profit$62.0M-1.2%
Operating income-$165.8M-811%
Net income-$160.8M-237%
EPS (diluted)-$3.49-236%

Balance sheet

See full
Cash & equivalents$125.2M
Total debt$55.7M
Total equity$1.6B-8.3%
Total assets$1.9B

Cash flow

See full
Operating cash flow$13.5M-6.2%
CapEx$7.4M-0.1%
Free cash flow$6.1M-12.7%

Valuation

See full
Market cap$1.1B-19.0%
Enterprise value$1.03B
P/S1.8×-0.3×

Profitability

See full
Gross margin40%-1.0pp
Operating margin-31.6%-59.7pp
Net margin-29.1%-80.7pp
FCF margin8.6%

Returns & leverage

See full
Return on equity-10.7%-22.4pp
Debt / equity
Current ratio2.8×

Where this comes from

Reported directly by Azenta in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Azenta’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Azenta's asia pacific (excluding china) — total revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Azenta's asia pacific (excluding china) — total revenue?
Azenta (AZTA) reported asia pacific (excluding china) — total revenue of $7.53M in Q1 2026.
What does asia pacific (excluding china) — total revenue mean?
This metric represents the total gross revenue generated from sales of products and services within the Asia Pacific geographic region, specifically excluding operations in China. It serves as a key indicator of the company's market penetration and demand for life sciences solutions in emerging and developed Asian markets outside of the Chinese mainland. Tracking this revenue stream helps investors assess geographic diversification and regional growth strategies.